{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:37:14Z","timestamp":1790397434365,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.medmal.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T19:14:32Z","timestamp":1523906072000},"page":"410-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France"],"prefix":"10.1016","volume":"48","author":[{"given":"C.","family":"Duployez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vach\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.medmal.2018.03.010_bib0045","doi-asserted-by":"crossref","first-page":"e9233","DOI":"10.1371\/journal.pone.0009233","article-title":"Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use","volume":"16;5","author":"Brolund","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.medmal.2018.03.010_bib0050","article-title":"Diagnostic et antibioth\u00e9rapie des infections urinaires bact\u00e9riennes communautaires de l\u2019adulte","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF)","year":"2015","journal-title":"Recommandations Argumentaire"},{"key":"10.1016\/j.medmal.2018.03.010_bib0055","series-title":"Commission de la transparence trim\u00e9thoprime","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2016"},{"issue":"1","key":"10.1016\/j.medmal.2018.03.010_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited","volume":"1;39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrobial Agents"},{"key":"10.1016\/j.medmal.2018.03.010_bib0065","unstructured":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 fran\u00e7aise de microbiologie. CASFMV2_030915. http:\/\/www.sfm-microbiologie.org\/UserFiles\/files\/casfm\/CASFMV2_030915.pdf. Accessed March 10, 2017"},{"issue":"2","key":"10.1016\/j.medmal.2018.03.010_bib0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkp387","article-title":"Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use","volume":"65","author":"Sundqvist","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"22","key":"10.1016\/j.medmal.2018.03.010_bib0075","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and the risk of birth defects","volume":"30;34","author":"Hern\u00e1ndes-D\u00edaz","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.medmal.2018.03.010_bib0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/AAC.23.4.617","article-title":"Isolation of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae from urinary tract infections","volume":"23","author":"Towner","year":"1983","journal-title":"Antimicrob Agents Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17307266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17307266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:16:40Z","timestamp":1759972600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17307266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0399077X17307266"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.03.010","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}